Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Completed · Phase 4 · Has a placebo group

Conditions studied: Acute Upper Respiratory Track Infection

In brief

The purpose of this study is to determine if treatment with Mucinex D lowers the use of antibiotics in the treatment of upper respiratory infection when compared to placebo

Key facts

Study ID
NCT01202279
Run by
Reckitt Benckiser Inc.
People needed
1179
Starts
2009-10-01
Expected to finish
2010-07-01
Last updated by the study team
2020-12-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.